Skip to content
Search

Latest Stories

FEATURE: Get ready for winter

Will Pike argues how community pharmacists could help patients shift their mindset to think pharmacy first as the sector heads into a challenging winter…

Usually as we head into winter, we can all predict what our patients will be asking us about. But, just like the rest of the year has been like no other in community pharmacy, I’d expect this winter to be different too. This will present us with challenges, but also some great opportunities too.


One shift we have seen over the last seven months of Covid is that more and more people in the community are turning to their pharmacy for help, support and advice. With our doors remaining open throughout the height of the pandemic, we’ve established ourselves firmly at the heart of local healthcare – a trend I’d expect to see continue over the winter, especially now that a second wave, it seems, is upon us.

I think there’s three different types of patients who we’ll be seeing this winter coming to us for help and advice.

First, we’ll see those with a simple winter illness – for example, a common cold. For these patients our advice will be focused around self-care and home treatments. There is a wide range of products that we can recommend in the pharmacy from decongestants to combination products such as Night Nurse and nasal sprays.

This is a great opportunity to suggest the right Pharmacy Only Medicine for the patient, something they may not have considered before. But it’s not just about selling a medicine, we should also advise how the patient should keep themselves warm and well hydrated and advise them about multivitamins and supplements if we feel they may not be getting their requirements from their diet.

If they’re more vulnerable, then also checking that they have some support at home is also a good move. The NHS recommends 400iu of vitamin D over winter as deficiency in vitamin D is associated with increased autoimmunity as well as an increased susceptibility to infection.

Next up, we’ll see those who are perhaps suffering from more complex conditions including exacerbations of asthma or COPD. My advice here is to maintain great patient care by reinforcing the best inhaler technique and always recommend keeping a spare reliever inhaler in stock.

Each winter I direct patients to their GP for a rescue pack to keep in their medicine cabinet in case of severe exacerbations. I will be especially vigilant this winter as we want to keep our most vulnerable respiratory patients out of GP surgeries and the pharmacy if they get ill, so having the right tools at home for them is absolutely essential.

This in turn will help reduce hospital admissions this winter. As always we will be encouraging patients to stop smoking and offer a wide range of products in store to help people on this journey.

Then there are those who will need guiding to other services and support. We’re likely to see more of this as people perhaps avoid their GP – either through choice or necessity – and seek out some face-to-face advice. A specific challenge we’re going to face this year is around how some Covid symptoms are similar to those of the flu. Make sure all the team are aware and confident with what different symptoms mean – and keep abreast of any new developments in case new symptoms of Covid get added to the list.

Some patients may just need reassurance around what their symptoms mean, but I’d advise you know how to direct people to get tested and what self-isolation measures they should take if you suspect Covid.

It won’t have escaped anyone’s attention I’m sure the extra emphasis that the government are pushing on getting the flu jab this year. If this is something that you offer, then we must all play our part in helping achieve the levels of vaccination asked for this year.

But we must be responsible. We must explain that the flu vaccination won’t necessarily stop Covid, but it might provide a much-needed boost to the adaptive immune system and may enhance the immune response against a range of pathogens this winter.

However, given how the symptoms of flu and Covid are similar, if a patient has had the flu jab and then show flu-like symptoms, they’ll know to treat this more seriously and not shrug it off as a cold.

It’s also worth thinking about – where available – taking the time with flu jab patients to explain the benefits that a pneumococcal vaccination would also give. With such an emphasis on the flu jab, it’s easy for patients to not even think that there might be something else that can help them stay healthy over the winter.

So, while we may expect to be busier this winter, our core focus is the same – helping patients with their immediate medication needs, but also providing advice as a trusted healthcare professional on how they can prevent themselves from falling foul to winter illnesses in the first place.

And this winter, with the threat of a second wave of Covid seemingly never far away, we have a unique opportunity to encourage patients keep their medicine cabinets stocked up with common OTC products such as loperamide, decongestants, pain killers and linctus so they’re ready to fight whatever winter throws at them even if they have to self-isolate.

And finally, I’d recommend that you reassure your patients that their pharmacist is only a phone call away for advice, particularly if they should need to self-isolate. This is how we’ll help patients shift their mindset to think pharmacy first.

Will Pike is a pharmacist at a Well pharmacy branch in Wonford, Devon.

This feature also appears in the print edition of Pharmacy Business/Oct 2020. 

More For You

Skill mix and independent prescribing: The essential ingredients for pharmacy’s future

L-R: Nicola Stockmann, Robert Townsend, Atul Patel, and Amerjit Singh

Skill mix and independent prescribing – Key to driving pharmacy forward

“The workforce is your greatest asset,” said Nicola Stockmann, president of the Association of Pharmacy Technicians UK (APTUK).

Speaking at the recent Pharmacy Business Conference, she emphasised that investing in the entire pharmacy team, including pharmacy technicians and assistants, is essential for sustainable growth.

Keep ReadingShow less
How community pharmacies can safely and profitably deliver high-quality NHS and private services

L-R: Baba Akomolafe, Rachna Chhatralia, Patricia Tigenoah-Ojo, and Raj Matharu

How community pharmacies are optimising services for a sustainable future

“Community pharmacy has come to a point where we have to change ourselves,” said Raj Matharu, CEO at Community Pharmacy South East London, and Superintendent Pharmacist of Westchem Pharmacy, as he opened a panel discussion at the recent Pharmacy Business Conference.

The 'Optimising Service Opportunities' session centred on how community pharmacies can safely and profitably deliver high-quality NHS and private services, while ensuring an excellent patient experience.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Janet Morrison discusses pharmacy funding strategy at 2025 conference

Health Secretary Wes Streeting outlines government support for community pharmacy

CPE calls new funding deal a ‘reluctant yes’

Community Pharmacy England (CPE) was “reluctant” to accept the new pharmacy funding deal due to the significant funding gap, said the organisation’s chief executive Janet Morrison, while recognising the settlement as the first step towards stabilising the sector.

Addressing the 2025 Pharmacy Business Conference on Sunday at London Hilton Wembley, Janet shared insights into the behind-the-scenes work that led to the agreement.

Keep ReadingShow less